Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine to prevent anthracycline-induced cardiotoxicity
2019-000661-20Phase 4Completed
- Sponsor
- Vilnius University Hospital Santaros Klinikos
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ivabradine in leukemia, lymphoma, breast cancer and 6 more (2 arms), sponsored by Vilnius University Hospital Santaros Klinikos. Primary endpoint: Incidence of left ventricular dysfunction by GLS reduction. Started Apr 2019; status: completed.
02
Drugs
ivabradine
03
Conditions
leukemialymphomabreast cancergastric cancer (GC)uterine cancer
Beyond the preview
Go deeper on 2019-000661-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000661-20.